Case Report: A patient with familial dyslipidemia fails to respond to statins Got patients with a-fib? You need to read thisRecent studies evaluate biomarkers for risk assessment and compare oral anticoagulants Pharmacist-directed dyslipidemia care improves cholesterol management Pharmacist prescribing and monitoring of lipid-lowering therapy enables more patients with uncontrolled dyslipidemia to reach LDL-C targets. A heart attack is hard on younger patients’ sex life Women suffer more than men in the year after an acute MI, study finds Psoriasis and heart disease: ‘Major educational efforts’ needed Coronary arteries in just as bad a shape as those in type 2 diabetes patients Patient doing well on warfarin? Check again Stability is elusive for patients on long-term anticoagulation 2016 Canadian dyslipidemia guidelines Despite controversy, experts continue to recommend LDL-C targets for patients started on lipid-lowering therapy. Watch for drugs that can cause or worsen heart failure New AHA statement identifies potentially problematic drugs and provides tips for minimizing polypharmacy. Upsurge in ER visits for hypertension Inadequate patient information about interpreting home BP monitor readings may be a contributing factor. Hydroxyzine increases risk of QT prolongation/torsade de pointes in some patients Health Canada reduces maximum daily oral doses and issues new contraindications. First Previous 35 36 37 38 39 Next Last
